Skip to main content

Prediction of Heart Failure Hospitalization or Death After TAVR.

Publication ,  Journal Article
El-Sabawi, B; Manandhar, P; Butler, J; Généreux, P; Dweck, MR; Treibel, TA; Cohen, DJ; Desai, N; Thourani, VH; Batchelor, W; Mack, M; Leon, MB ...
Published in: Circ Cardiovasc Interv
December 31, 2025

BACKGROUND: Heart failure (HF) remains a significant burden following transcatheter aortic valve replacement, adversely impacting survival and quality of life. Identification of patients who may benefit from closer monitoring or adjunctive medical therapy to reduce the risk of HF is an unmet need. The objective of this study was to develop and internally validate a clinical prediction model to determine the 1-year risk of HF hospitalization or death after transcatheter aortic valve replacement. METHODS: Using the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry, we analyzed patients who underwent successful transcatheter aortic valve replacement for aortic stenosis and survived to discharge between 2016 and 2019. Covariates were selected based on expert opinion and prior literature. A hierarchical cumulative odds regression model was used to predict a composite outcome of (1) all-cause death, (2) ≥2 HF readmissions, or (3) 1 HF readmission at 1 year. RESULTS: Among 78 384 patients (median age, 82 years; 45.6% female), 17.4% experienced the composite outcome, including death (10.9%), ≥2 HF readmissions (1.6%), and 1 HF readmission (4.9%). The model demonstrated good discrimination (C statistic, 0.753 derivation and 0.747 validation) and excellent calibration. Among 1-year survivors, performance in predicting HF readmission as an isolated outcome was similar (C statistic, 0.753). A simplified model, including the top 12 variables from the full model, maintained comparable performance (C statistics, 0.74-0.75). CONCLUSIONS: This prediction model effectively stratifies post-transcatheter aortic valve replacement patients by risk of death or HF readmission, supporting its use to guide clinical surveillance and clinical trial enrollment for adjunctive medical therapies aimed at mitigating this risk.

Duke Scholars

Published In

Circ Cardiovasc Interv

DOI

EISSN

1941-7632

Publication Date

December 31, 2025

Start / End Page

e015398

Location

United States

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
El-Sabawi, B., Manandhar, P., Butler, J., Généreux, P., Dweck, M. R., Treibel, T. A., … Lindman, B. R. (2025). Prediction of Heart Failure Hospitalization or Death After TAVR. Circ Cardiovasc Interv, e015398. https://doi.org/10.1161/CIRCINTERVENTIONS.125.015398
El-Sabawi, Bassim, Pratik Manandhar, Javed Butler, Philippe Généreux, Marc R. Dweck, Thomas A. Treibel, David J. Cohen, et al. “Prediction of Heart Failure Hospitalization or Death After TAVR.Circ Cardiovasc Interv, December 31, 2025, e015398. https://doi.org/10.1161/CIRCINTERVENTIONS.125.015398.
El-Sabawi B, Manandhar P, Butler J, Généreux P, Dweck MR, Treibel TA, et al. Prediction of Heart Failure Hospitalization or Death After TAVR. Circ Cardiovasc Interv. 2025 Dec 31;e015398.
El-Sabawi, Bassim, et al. “Prediction of Heart Failure Hospitalization or Death After TAVR.Circ Cardiovasc Interv, Dec. 2025, p. e015398. Pubmed, doi:10.1161/CIRCINTERVENTIONS.125.015398.
El-Sabawi B, Manandhar P, Butler J, Généreux P, Dweck MR, Treibel TA, Cohen DJ, Desai N, Thourani VH, Batchelor W, Mack M, Leon MB, Lindenfeld J, Lowenstern A, Kosinski AS, Vemulapalli S, Lindman BR. Prediction of Heart Failure Hospitalization or Death After TAVR. Circ Cardiovasc Interv. 2025 Dec 31;e015398.

Published In

Circ Cardiovasc Interv

DOI

EISSN

1941-7632

Publication Date

December 31, 2025

Start / End Page

e015398

Location

United States

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology